The nation of Zimbabwe has rejected a significant US health deal worth $367m (£272m) spanning five years because of the United States' insistence on sensitive information.
This rejection was revealed after a government memo from December was leaked, revealing that President Emmerson Mnangagwa believed the agreement was "unbalanced".
An official spokesman has since clarified that the United States was seeking genetic material for scientific study and commercial purposes but was unwilling to share the resulting advantages from future treatments.
"We will now turn to the challenging and unfortunate task of winding down our support in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy said the United States had donated over $1.9bn for health programmes to Zimbabwe over the last two decades.
A medical body in Zimbabwe has called for further dialogue to reach a deal suitable to all parties so the nation's vital HIV programme can proceed.
Wider Implications
This rejection follows a comparable case in Kenya, where a court suspended a related deal with the US after concerns were filed about the security of Kenyans' health data.
Since returning to the presidency recently, US President Donald Trump has slashed foreign aid and closed the US Agency for International Development (USAID).
The agency had overseen assistance for the US government, but Trump argued its expenditure was "inefficient" and his government was seeking direct bilateral deals to boost transparency and responsibility.
As per reports, Sixteen nations in Africa have so far agreed to these new agreements, representing more than $18.3bn of fresh investment.
Specifics of the Rejected Deal
The funds for Zimbabwe was intended to gone towards "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"It is our view this partnership could have provided significant benefits for the people of Zimbabwe, especially the 1.2 million presently on HIV treatment through American-funded initiatives," the Ambassador said.
However, government spokesperson Nick Mangwana said the arrangement was "unequal".
"The proposal required Zimbabwe to provide its biological resources and data indefinitely, without any corresponding guarantee of benefiting from any scientific breakthroughs – like new medicines or tests – that could be developed from that provided information," he stated.
"Effectively, our country would provide the raw materials for medical research without any certainty that the end products would be available to our population if a new disease outbreak arise."
Sovereignty and International Frameworks
Mangwana further noted that the American exit from the World Health Organization (WHO) and its push of bilateral health agreements were undermining systems already set up via the international organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing system created to manage potential pandemics.
"This mechanism is designed to ensure that when a nation contributes its information, the benefits – including vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the capability to develop them."
These objections over the US deal "should not be misconstrued as hostility towards the US," he added.
"We are open to ongoing discussions with our American counterparts on how subsequent collaboration could be arranged in a way that honours the sovereignty and interests of both nations."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it understood the government's concerns, but suggested that talks should continue given that a large portion of the country's Aids initiatives relied on external financing.
"In cases where specific concerns arise, such as those relating to data governance or implementation frameworks, these can often be resolved via detailed discussion and negotiated safeguards," it added.
The halted deal highlights the continuing debate between accepting much-needed foreign assistance and protecting national sovereignty in an increasingly interconnected world.